prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumA, SPECIMENS: A. SENTINEL LYMPH NODE #1 RIGHT AXILLA. B. SENTINEL LYMPH NODE #2 RIGHT AXILLA. C. RIGHT BREAST. D. SENTINEL LYMPH NODE #3 RIGHT AXILLA. SPECIMEN(S): A. SENTINEL LYMPH NODE #1 RIGHT AXILLA. B. SENTINEL LYMPH NODE #2 RIGHT AXILLA. C. RIGHT BREAST. D. SENTINEL LYMPH NODE #3 RIGHT AXILLA. INTRAOPERATIVE CONSULTATION DIAGNOSIS: TPA/TPB/TPC: negative for tumor, by Dr. to Dr. at. (A,B) and. (C). GROSS DESCRIPTION: A. SENTINEL LYMPH NODE #1, RIGHT AXILLA. Received fresh is a 1.4 x 0.6 x 0.4 cm lymph node. One touch prep is performed. Lymph node is. submitted entirely in cassette A1. B. SENTINEL LYMPH NODE #2. Received fresh is a 1.2 x 0.7 x 0.4 cm lymph node. One touch prep is performed. Lymph node is. submitted entirely in cassette B1. C. RIGHT BREAST. Received fresh labeled with the patient's identification and "Right breast" is an oriented 636g, 21 x 16 x. 3cm mastectomy with 7 x 3.5cm skin ellipse and 1.5cm partially inverted nipple. Ink code: anterior/superior-blue, anterior/inferior-orange, posterior-black. Specimen is serially sectioned into 11. slices from medial to lateral with nipple in slice 5 revealing several lesions: 1) 2 x 1.8 x 1.5 cm white-tan firm infiltrating subareolar mass in slice 5 that is closest to the anterior. margin at 1.3 cm. 2) 1.2 x 0.5 x 0.5 cm biopsy site at 12:00 in slice 5 that is 1 cm from the anterior margin and 2.5 cm. superior to lesion #1. 3) 0.6 x 0.5 x 0.5 cm that is present in UOQ in slice 6 that is 1 cm lateral to lesion #1 and 2 cm from the. deep margin. 4) 1 x 0.7 x 0.5 cm in UOQ, slice 8, that is 0.3 cm lateral to lesion #3 and is greater than 1 cm from all. margins. Tissue is procured. Representatively submitted: C1-C4: slice 5, lesion #1 including relationship to nipple and skin. C5: slice 5, fibrous tissue connecting lesion 1 and lesion 2. C6-C7: slice 5, lesion #2. C8-C9: slice 6, lesion #3. C10: slice 6, fibrous tissue nearest deep margin. C11: slice 7, granular tissue. C12: slice 8, lesion #4. C13: slice 9, granular tissue. C14: slice 10, lower outer quadrant including anterior margin. C15: slice 3, lower inner. C16: slice 4, upper inner. D. SENTINEL LYMPH NODE #3 RIGHT AXILLA. Received fresh is a 0.7 X 0.5 X 0.3 cm lymph node. One touch prep is performed. Lymph node is. submitted entirely in cassette D1. DIAGNOSIS: A. SENTINEL LYMPH NODE #1, RIGHT AXILLA, BIOPSY: - MICROMETASTATIC CARCINOMA TO ONE LYMPH NODE (1/1) (SEE NOTE). NOTE: There is one focus of micrometastatic carcinoma in the capsule measuring 0.27 mm and. another focus of isolated tumor cells in the capsule that is 0.18 mm. No extranodal extension is present. The touch prep was reviewed and shows no evidence of tumor. B. SENTINEL LYMPH NODE #2, RIGHT AXILLA, BIOPSY: - ONE LYMPH NODE, NO TUMOR SEEN (0/1). C. BREAST, RIGHT, MASTECTOMY: - MULTICENTRIC. INVASIVE DUCTAL CARCINOMA, SBR GRADE 2,. WITH MUCIN, INVOLVING SKIN DERMIS (SEE NOTE). - TUMOR MEASURES 2.3 CM, 0.9 CM, 0.6 CM, AND 0.2 CM. - MARGINS, NO TUMOR SEEN. - DUCTAL CARCINOMA IN SITU (DCIS), NUCLEAR GRADE 2, SOLID AND. CRIBRIFORM TYPES, INVOLVING LOBULES. - PREVIOUS BIOPSY SITE CHANGES PRESENT. NOTE: Several foci of tumor are identified - 2.3 cm subareolar, 0.9 cm at 12:00, 0.2 cm between the. subareolar and 12:00 tumors, and 0.6 cm in the upper outer quadrant. D. SENTINEL LYMPH NODE #3, RIGHT AXILLA, BIOPSY: - ONE LYMPH NODE, NO TUMOR SEEN (0/1). SYNOPTIC REPORT - BREAST. Specimen Type: Mastectomy. Needle Localization: No. Laterality: Right. Invasive Tumor: Present. Multifocality: Yes. WHO CLASSIFICATION. Invasive ductal carcinoma, NOS 8500/3. Tumor size: 2.3cm. Tumor Site: Upper outer quadrant. Central. Margins: Negative. Distance from closest margin: Greater than 1cm. all margins. Tubular Score: 2. Nuclear Grade: 2. Mitotic Score: 2. Modified Scarff Bloom Richardson Grade: 2. Necrosis: Absent. Vascular/Lymphatic Invasion: None identified. Lobular neoplasia: None. Lymph nodes: Sentinel lymph node only. Lymph node status: Positive 1 /3 Isolated tumor cell clusters. Micrometastases: DCIS present. Margins uninvolved by DCIS. DCIS Quantity: Estimate 25%. DCIS Type: Solid. Cribriform. DCIS Location: Associated with invasive tumor. Nuclear grade: Intermediate. Necrosis: Absent. ER/PR/HER2 Results. ER: Positive. PR: Positive. HER2: Negative by IHC. Pathological staging (pTN): pT 2 N 1 mi. CLINICAL HISTORY: Multicentric invasive cancer right breast. PRE-OPERATIVE DIAGNOSIS: Right breast cancer. Microscopic/Diagnostic Dictation: , M.D., Pathologist,. Final Review: , M.D., Pathologist. Final: , M.D., Pathologist,. 1.

expanded version (tokens=1924) : 
 The breast pathology report states multiple findings:

1. Histological classification: The subtype of breast cancer is LumA. The tumor is a multicentric invasive ductal carcinoma with associated ductal carcinoma in situ (DCIS) that involves lobules. The DCIS is of nuclear grade 2, with solid and cribriform types.

2. Necrosis: Absent.

3. Tumor infiltrating lymphocytes: Not mentioned in the report.

4. Histological grade: SBR grade 2, tubular score 2, nuclear grade 2, mitotic score 2, and modified Scarff Bloom Richardson grade 2.

5. Lymphovascular invasion: None identified.

6. Calcification: Not mentioned in the report.

7. Receptor status: Estrogen receptor (ER) and progesterone receptor (PR) are positive, and human epidermal growth factor receptor 2 (HER2) is negative by immunohistochemistry (IHC).

8. Ancillary testing: No other ancillary testing results are mentioned in the report.

9. Lymph node involvement: One out of three sentinel lymph nodes has micrometastatic carcinoma. No tumor is seen in the other two sentinel lymph nodes.

Overall, the report shows an early stage of breast cancer as only one out of three sentinel lymph nodes has micrometastatic carcinoma, which indicates a low risk of spreading to other parts of the body. The patient's receptor status shows a

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=2059) : 
 The breast pathology report suggests a LumA subtype multicentric invasive ductal carcinoma with associated DCIS involving lobules. Lymphovascular invasion and necrosis are absent. Sentinel lymph node biopsy indicates micrometastatic carcinoma in one out of three lymph nodes without extranodal extension. ER and PR are positive, and HER2 is negative by IHC. The diagnosis is a stage pT2N1mi breast cancer.

